Delivery Order SPE2DE24DA010-SPE2D625F5F00

Award Date 3/13/25
Potential Completion Date 3/18/25
Potential Value $21K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract, valued at $25,364.85, was awarded by the Defense Logistics Agency (DLA) and is a fixed-price delivery order contract with economic price adjustment. The contract has a completion date of February 5, 2025 and does not include a set-aside designation, indicating full and open competition....
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, for the delivery of cardiovascular medical devices and related services. The $68,700.00 fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA), an agency within the Department of Defense, without any set-aside designation, indicating full and open competition. The contract covers a range of cardiovascular technologies, including stents, pacemakers, heart valves, implantable...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm fixed-price delivery order with economic price adjustment, with an ultimate completion date of June 18, 2024. The award provides for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants....
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, by the Defense Logistics Agency (DLA) and Department of Veterans Affairs (VA). The contract has an award value of $25,715.85 and is a firm fixed-price delivery order with economic price adjustment. The contract covers the delivery of a variety of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and...
This federal contract award, valued at $25,875.85, was made by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract is a delivery order for the provision of cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside...
This federal contract award, valued at $29,273.85, was issued by the Medical Supply Chain division of the Defense Agency to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract is a fixed price with economic price adjustment delivery order with a completion date of November 25,...
This federal contract award, valued at $105,000.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for fixed-price medical equipment with economic price adjustment, with a completion date of February 21, 2025. The products being delivered include a range of cardiovascular medical devices such as stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $2,800.00 fixed-price with economic price adjustment delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of June 17, 2024. This award is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $44,742.80 fixed-price delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and surgical implants. The ultimate completion date for this contract is October 25, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F5F00
    Delivery Order

This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The award has a ceiling value of $21,425.00 and is a fixed-price delivery order contract with economic price adjustment, awarded by the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD) and other federal healthcare systems.

The contract covers a range of specialized cardiovascular products, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and surgical implants. Abbott Laboratories Inc. has demonstrated its ability to provide comprehensive procedural solutions, including 24/7 technical support and on-site expertise, to assist medical staff in effectively utilizing these advanced medical technologies. This contract award is not designated as a set-aside and was awarded through full and open competition. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $117.14 million that the company holds with the DLA to provide a broad range of cardiovascular medical equipment and services to federal healthcare systems.

Generated 6/13/25, 10:07 AM